Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,412.00    -18.00 (-0.41%)
Bid:
4,410.00
Ask:
4,416.00
Spread: 6.00 (0.136%)
Market Cap: £2.06b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Trading Update

2 Nov 2023 07:00

RNS Number : 0992S
Morgan Sindall Group PLC
02 November 2023
 

 

2 November 2023

 

 

Morgan Sindall Group plc

 

Trading Update

Morgan Sindall Group plc ("the Group") today provides an update on current trading and the outlook for the 2023 financial year.

Group performance and outlook

Since the time of the half year results on 3 August 2023, general market conditions have remained challenging yet manageable. Based on the performance to date and with good visibility of secured orders through to the end of the year, the Group remains on track to deliver a full year performance in line with its expectations, with strength in Fit Out, Construction and Infrastructure offsetting a weaker performance in Property Services.

Divisional summaries

Both Construction and Infrastructure have performed better than expected, with each continuing to benefit from their ongoing focus on long-term client relationships, operational delivery and risk management.

Fit Out has continued to trade strongly and with the visibility of its order book for the rest of the year, it is now well-placed to deliver a result for the full year which is slightly above the top end of its medium-term target1.

In Property Services, contract performance has remained difficult. Although the remediation programme being implemented to address operational delivery and contract pricing has made some positive progress, this has been slower than expected and the loss in the year is now anticipated to be higher than previously expected.

Partnership Housing has progressed as planned, with the focus on long-term partnerships with the public sector continuing to provide some resilience against the softer housing market. Average capital employed for the year is expected to be c£250m.

In Urban Regeneration, progress on the various schemes within its development portfolio has been broadly as expected, albeit procurement and planning processes are increasingly protracted. Average capital employed for the year is expected to be c£100m and the return on capital expected to be around the 'mid-teens'.

1 Fit Out's medium-term target is annual operating profit within the range of £50m-£70m

Group secured workload

The Group has a growing and high-quality workload. The total secured order book for the Group at 30 September 2023 was £9.1bn, up 7% from the year end position (level with the half year).

Balance sheet

The average daily net cash for the period from 1 January to 27 October was £275m (of which £44m relates to amounts held in jointly controlled operations or held for future payment to designated suppliers).

The average daily net cash for the full year is expected to be around £270m, slightly higher than previous guidance.

 

John Morgan, Chief Executive, said:

"General market conditions remain challenging yet manageable. Against this backdrop, our high-quality secured order book and our operational delivery capabilities give us great confidence for the rest of the year and we're on track to deliver a full year performance which is in line with our expectations."

ENDS

 

Morgan Sindall Group

John Morgan

Steve Crummett

 

Brunswick

Jonathan Glass

Nina Coad

Tel: 020 7307 9200

 

 

 

Tel: 020 7404 5959

 

Note to Editors

Morgan Sindall Group

Morgan Sindall Group plc is a leading UK Construction & Regeneration group with annual revenue of £3.6bn, employing around 7,600 employees and operating in the public, regulated and private sectors. It reports through six divisions of Construction, Infrastructure, Fit Out, Property Services, Partnership Housing and Urban Regeneration.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKDBKOBDDPDK
Date   Source Headline
4th Jun 202611:43 amRNSDirector/PDMR Shareholding
3rd Jun 202611:56 amRNSDirector/PDMR Shareholding
1st Jun 20269:27 amRNSTotal Voting Rights
27th May 20261:29 pmRNSAdmission to Trading
20th May 202611:35 amRNSIssue of Equity
7th May 202612:38 pmRNSResult of AGM
1st May 20261:33 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSTotal Voting Rights
20th Apr 20263:44 pmRNSHolding(s) in Company
16th Apr 20264:09 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSTrading and Outlook for 2026
14th Apr 20262:18 pmRNSAdmission to Trading
1st Apr 20269:53 amRNSTotal Voting Rights
26th Mar 20261:27 pmRNSHolding(s) in Company
24th Mar 202612:56 pmRNSAnnual Financial Report
20th Mar 202612:42 pmRNSIssue of Equity
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
4th Mar 20262:38 pmRNSDirector/PDMR Shareholding
4th Mar 20262:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:33 pmRNSIssue of Equity / Admission to Trading
2nd Mar 20269:22 amRNSTotal Voting Rights
26th Feb 20269:53 amRNSDirector Declaration
25th Feb 20267:00 amRNSResults for the Full Year ended 31 December 2025
12th Feb 20267:00 amRNSTrading and Outlook for 2026
2nd Feb 20269:13 amRNSTotal Voting Rights
19th Jan 20267:00 amRNSNotice of Full Year Results
2nd Jan 202611:09 amRNSTotal Voting Rights
16th Dec 202510:16 amRNSAdditional Listing
2nd Dec 20259:12 amRNSTotal Voting Rights
25th Nov 20254:14 pmRNSHolding(s) in Company
12th Nov 20254:07 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:58 amRNSTotal Voting Rights
20th Oct 202511:24 amRNSBlock listing Interim Review
20th Oct 20259:32 amRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSTrading Update and Outlook for 2025
1st Oct 20259:05 amRNSTotal Voting Rights
1st Sep 20258:59 amRNSTotal Voting Rights
4th Aug 20253:09 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults For the Half Year (HY) Ended 30 June 2025
18th Jul 20258:40 amRNSHolding(s) in Company
1st Jul 20259:34 amRNSTotal Voting Rights
25th Jun 20258:47 amRNSAdditional Listing
24th Jun 20257:00 amRNSNotice of Half Year Results
17th Jun 20257:00 amRNSTrading Update and Outlook for 2025
16th Jun 20251:55 pmRNSDirector/PDMR Shareholding
2nd Jun 20253:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.